Quantcast

Latest Valeant Pharmaceuticals Stories

2014-05-28 00:21:31

LAVAL, Quebec, May 28, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has entered into an agreement with Nestle S.A. to sell all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in cash. Nestle expects to complete its acquisition of Galderma S.A. in July and would expect to operate the acquired assets through Galderma. The transaction is subject to customary closing...

2014-05-27 20:22:14

LAVAL, Quebec, May 27, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) announced today that the company is hosting an in-person meeting for Allergan and Valeant shareholders tomorrow at 8:00 a.m. ET (5:00 a.m. PT) at the AXA Equitable Auditorium, 787 Seventh Avenue (between 51st and 52nd Streets), New York, New York to respond to assertions Allergan has made that the Valeant model is not sustainable, that the Bausch + Lomb portfolio is not...

2014-05-27 12:32:51

DUBLIN, May 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/mkpzcg/global_glaucoma) has announced the addition of the "Global Glaucoma Therapeutics Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of optic nerve damage due to glaucoma is...

2014-05-23 08:24:05

LAVAL, Quebec, May 23, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference 2014 on Wednesday, May 28, 2014 at 4:00 p.m. ET. The conference will be held at The Waldorf Astoria in New York. A live webcast and audio archive of the presentation will be available on the company's Web site at...

2014-05-21 08:30:04

LOS ANGELES, May 21, 2014 /PRNewswire/ -- Research Solutions, Inc. (OTC-PINK: RSSS), a pioneer in facilitating the flow of information from the publishers of scientific, technical, and medical content to enterprise customers in Life Sciences and other research intensive organizations around the world, today announced that Valeant Pharmaceuticals had adopted Bibliogo, the literature management and collaboration web application add-on for the company's Article Galaxy...

2014-05-21 08:29:08

LAVAL, Quebec, May 21, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2014 annual meeting of shareholders today. The detailed results of the vote for the election of directors are set out below: Name For Withheld Broker Non-Votes ---- --- -------- ---------------- Ronald H. Farmer 251,288,239...

2014-05-20 12:28:25

LONDON, May 20, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Dermatological Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_dermatological_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market's growth is an increase in the aging population worldwide....

2014-05-20 08:32:50

LAVAL, Quebec, May 20, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) announced today that the company will host an in-person meeting for Allergan and Valeant shareholders on May 28, 2014 at 8:00 a.m. ET (5:00 a.m. PT) at the AXA Equitable Auditorium, 787 Seventh Avenue (between 51st and 52nd Streets), New York, New York to respond to assertions Allergan has made that the Valeant model is not sustainable, that the Bausch + Lomb portfolio...

2014-05-20 08:31:59

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding The Chubb Corporation (NYSE: CB), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), AstraZeneca Plc (NYSE: AZN), Mylan, Inc. (NASDAQ: MYL) and Perrigo Co. (NYSE: PRGO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are...

2014-05-13 08:32:00

LAVAL, Quebec, May 13, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today responded to Allergan, Inc.'s (NYSE: AGN) rejection of Valeant's proposal to combine with Allergan for $48.30 in cash and 0.83 shares of Valeant common stock for each Allergan share: Dear Allergan Shareholders, As you are all aware, yesterday we received Allergan's letter rejecting Valeant's offer. We note that our offer was rejected without Allergan having had any...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related